Genitourinary Cancer
News
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Patients with High-Risk Prostate Cancer
News
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Patients With High-Risk Localized Prostate Cancer
News
Safety and Efficacy Study of Enzalutamide versus Bicalutamide in Men With Prostate Cancer (STRIVE)
News
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Patients with Advanced Urinary Tract Cancer
News
Lenalidomide Worsens Survival in Advanced Prostate Cancer
Major Finding: Median overall survival was 19.5 months in patient given lenalidomide plus docetaxel and prednisone but was not reached in the...
News
Abiraterone and Enzalutamide Thwart Prostate Cancer Pain
Major Findings: Abiraterone acetate reduced opiate use by 19%, and enzalutamide the risk of pain progression by 44%.
News
Pazopanib Edges Sunitinib as First-Line Kidney Cancer Therapy
Major Finding: Median progression-free survival was 8.4 months for pazopanib vs. 9.5 months for sunitinib by independent central review (hazard...
News
MRI Identifies Candidates for Prostate Cancer Surveillance
Major Finding: In a multivariate analysis, MRI scores showing the probable or definite presence of tumor were highly predictive that confirmatory...
News
HPV Vaccine's Benefits Are Mainly Extracervical
News
Active Surveillance Favored for Low-Risk Prostate Cancer
Major Finding: The predicted 20-year cumulative rate of prostate cancer–specific mortality showed 1.8 months of life saved per patient who chose...